We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cell state dependent effects of Bmal1 on melanoma immunity and tumorigenicity.
- Authors
Zhang, Xue; Pant, Shishir M.; Ritch, Cecily C.; Tang, Hsin-Yao; Shao, Hongguang; Dweep, Harsh; Gong, Yao-Yu; Brooks, Rebekah; Brafford, Patricia; Wolpaw, Adam J.; Lee, Yool; Weeraratna, Ashani; Sehgal, Amita; Herlyn, Meenhard; Kossenkov, Andrew; Speicher, David; Sorger, Peter K.; Santagata, Sandro; Dang, Chi V.
- Abstract
The circadian clock regulator Bmal1 modulates tumorigenesis, but its reported effects are inconsistent. Here, we show that Bmal1 has a context-dependent role in mouse melanoma tumor growth. Loss of Bmal1 in YUMM2.1 or B16-F10 melanoma cells eliminates clock function and diminishes hypoxic gene expression and tumorigenesis, which could be rescued by ectopic expression of HIF1α in YUMM2.1 cells. By contrast, over-expressed wild-type or a transcriptionally inactive mutant Bmal1 non-canonically sequester myosin heavy chain 9 (Myh9) to increase MRTF-SRF activity and AP-1 transcriptional signature, and shift YUMM2.1 cells from a Sox10high to a Sox9high immune resistant, mesenchymal cell state that is found in human melanomas. Our work describes a link between Bmal1, Myh9, mouse melanoma cell plasticity, and tumor immunity. This connection may underlie cancer therapeutic resistance and underpin the link between the circadian clock, MRTF-SRF and the cytoskeleton. It has been reported that the circadian clock regulator Bmal1 can modulate tumorigenesis. Here the authors show that ectopic expression of Bmal1 promotes an immune resistant mesenchymal melanoma cell state associated with increased AP-1 activity.
- Subjects
MELANOMA; GENE expression; IMMUNITY; TUMOR growth; MYOSIN
- Publication
Nature Communications, 2024, Vol 15, Issue 1, p1
- ISSN
2041-1723
- Publication type
Article
- DOI
10.1038/s41467-024-44778-2